Increased COVID-19 breakthrough infection risk in patients with plasma cell disorders

Blood. 2022 Aug 18;140(7):782-785. doi: 10.1182/blood.2022016317.
No abstract available

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • COVID-19 Vaccines
  • COVID-19* / complications
  • Humans
  • Paraproteinemias*
  • Plasma Cells
  • Risk Factors

Substances

  • COVID-19 Vaccines

Supplementary concepts

  • COVID-19 breakthrough infections